Ignite Creation Date:
2025-12-24 @ 2:43 PM
Ignite Modification Date:
2026-01-09 @ 6:35 AM
Study NCT ID:
NCT04854759
Status:
UNKNOWN
Last Update Posted:
2021-08-13
First Post:
2021-04-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms
Sponsor:
Independent Public Clinical Hospital No. 4 in Lublin
Organization:
Study Overview
Official Title:
The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms in Patients Infected With the SARS-CoV-2 Virus
Status:
UNKNOWN
Status Verified Date:
2021-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
COV-PREVENT
Brief Summary:
The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virus. Multicenter randomized, double-blind, placebo-controlled, non-commercial clinical trial
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: